NANOPARTICULATE FORMULATION COMPRISING A TRPA1 ANTAGONIST

• 收藏
• 分享

专利权人:

GLENMARK PHARMACEUTICALS S.A.

发明人:

Ulhas Rameshchandra DHUPPAD,Sunil Sudhakar CHAUDHARI,Suresh Mahadev RAJURKAR,Nilesh Jayantilal JAIN

申请号：

US14310447

公开号：

US20140377358A1

申请日:

2014.06.20

申请国别(地区):

US

年份:

2014

代理人:

摘要：

The present invention relates to a nanoparticulate formulation comprising a transient receptor potential ankyrin-1 receptor (“TRPA1”) antagonist. Particularly, the present invention relates to a nanoparticulate formulation comprising a thienopyrimidinedione derivative as a TRPA1 antagonist and a surface stabilizer； a process for preparing such formulation； and its use in treating a respiratory disorder or pain in a subject.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/